Unfortunately, PD-L1 IHC testing in HNSCC, as in other cancer types, has relatively high sensitivity but poor specificity for predicting response and disease control (poor positive predictive value, PPV; Lu et al. 2019; Burtness et al. 2019; Brockstein and Vokes 2023). This evidence concerns the gene CD274 and cancer.